ENOV logo

Enovis (ENOV)

Profile

Full Name

Enovis Corporation

Ticker Symbol

ENOV

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

May 8, 2008

Indexes

Not included

Website

http://www.enovis.com

Employees

7367

Key Details

Price

$37.18

Market Cap

$2.12B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$2.11B(+23.46% YoY)

Annual EPS

-$14.93(-2347.54% YoY)

PE Ratio

-

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$37.18
ENOV price is $37.18

Price All-time High

$128.95
ENOV price is currently -71.17% below its historical high of $128.95

Price Most Recent Change

-2.7%
ENOV price was down -2.7% on Apr 1, 2025

Price YTD Change

-15.27%
ENOV price is down -15.27% since January 1st

Price 1-year Change

-39.48%
ENOV price is down -39.48% year-on-year

Price 3-year Change

-46.78%
ENOV price is down -46.78% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$2.12B
ENOV market capitalization is $2.12 billion

Market Cap 3-year Change

-43.89%
ENOV market capitalization is down -43.89% over the past 3 years

Market Cap All-time High

$5.32B
ENOV market capitalization is currently -60.16% below its historical high of $5.32 billion

Market Cap Sector Rank

83.22%
ENOV market capitalization is higher than 83.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.87%
ENOV shares outstanding is up +3.87% year-on-year

Shares Outstanding 3-Year Change

+5.93%
ENOV shares outstanding is up +5.93% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.22
ENOV beta is 1.22

200-day SMA

$43.70
ENOV price is currently -14.91% below its 200-day simple moving average

50-day SMA

$41.75
ENOV price is currently -10.95% below its 50-day simple moving average

RSI

39.60
ENOV 14-day relative strength index is 39.60

Volume

0.71
ENOV 30-day relative volume is 0.71

ATR

$1.46
ENOV average true range is $1.46

10-day Historical Volatility

26.41%
ENOV 10-day historical volatility is 26.41%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$2.11B
ENOV annual revenue is $2.11 billion

Revenue Analysts Estimate

$2.22B
ENOV annual revenue is currently -4.85% lower than the consensus analysts' forecast

Revenue 1-year Change

+23.46%
ENOV annual revenue is up +23.46% year-on-year

Revenue Sector Rank

85.49%
ENOV annual revenue is higher than 85.49% of companies in Healthcare sector

EPS

EPS

-$14.93
ENOV annual earnings per share is -$14.93

EPS Analysts Estimate

$3.17
ENOV annual earnings per share is currently -571.13% lower than the consensus analysts' forecast

EPS 1-year Change

-2347.54%
ENOV annual earnings per share is down -2347.54% year-on-year

EPS Sector Rank

10.64%
ENOV annual earnings per share is higher than 10.64% of companies in Healthcare sector

Profit

Gross Profit

$1.18B
ENOV annual gross profit is $1.18 billion

Gross Margin

56.02%
ENOV annual gross profit margin is 56.02%

Operating Profit

-$103.43M
ENOV annual operating income is -$103.43 million

Operating Margin

-4.91%
ENOV annual operating profit margin is -4.91%

Net Income

-$825.49M
ENOV annual net profit is -$825.49 million

Net Margin

-39.17%
ENOV annual net profit margin is -39.17%

Expenses

Total Expenses

$2.21B
ENOV annual total expenses is $2.21 billion

Operating Expenses

$1.28B
ENOV annual total operating expenses is $1.28 billion

Cost Of Goods Sold

$926.87M
ENOV annual cost of goods sold is $926.87 million

Selling, General & Administrative Expenses

$1.03B
ENOV annual SGA is $1.03 billion

Depreciation And Amortization

$284.80M
ENOV annual depreciation & amortization is $284.80 million

Interest Expense

$57.10M
ENOV annual interest expense is $57.10 million

Income Tax

$4.49M
ENOV annual income tax is $4.49 million

EBIT & EBITDA

EBIT

-$765.82M
ENOV annual earnings before interest & taxes is -$765.82 million

EBITDA

-$481.03M
ENOV annual EBITDA is -$481.03 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$4.72B
ENOV annual total assets is $4.72 billion

Non Current Assets

$3.57B
ENOV annual long term assets is $3.57 billion

Current Assets

$1.15B
ENOV annual total current assets is $1.15 billion

Cash And Cash Equivalents

$48.17M
ENOV annual cash & cash equivalents is $48.17 million

Accounts Receivable

$407.03M
ENOV annual accounts receivable is $407.03 million

Inventory

$547.12M
ENOV annual inventory is $547.12 million

Liabilities

Total Liabilities

$2.15B
ENOV annual total liabilities is $2.15 billion

Long Term Liabilities

$1.63B
ENOV annual total long term liabilities is $1.63 billion

Current Liabilities

$529.00M
ENOV annual total current liabilities is $529.00 million

Accounts Payable

$179.10M
ENOV annual accounts payable is $179.10 million

Debt

Total Debt

$1.40B
ENOV annual total debt is $1.40 billion

Total Debt 1-year Change

+161.79%
ENOV annual total debt is up +161.79% year-on-year

Long Term Debt

$1.36B
ENOV annual long term debt is $1.36 billion

Short Term Debt

$42.37M
ENOV annual short term debt is $42.37 million

Equity & Capital

Shareholders Equity

$2.56B
ENOV annual stockholders equity is $2.56 billion

Book Value

$2.56B
ENOV annual book value is $2.56 billion

Retained Earnings

-$283.02M
ENOV annual retained earnings is -$283.02 million

Working Capital

$617.45M
ENOV annual working capital is $617.45 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$113.50M
ENOV annual cash flow from operations is $113.50 million

Cash From Operations 1-year Change

-15.92%
ENOV annual cash flow from operations is down -15.92% year-on-year

Cash From Investing

-$955.47M
ENOV annual cash flow from investing activities is -$955.47 million

Cash From Investing 1-year Change

-294.06%
ENOV annual cash flow from investing activities is down -294.06% year-on-year

Cash From Financing

$846.82M
ENOV annual cash flow from financing activities is $846.82 million

Cash From Financing 1-year Change

+562.63%
ENOV annual cash flow from financing activities is up +562.63% year-on-year

CAPEX

CAPEX

$180.71M
ENOV annual capital expenditures is $180.71 million

CAPEX 1-year Change

+47.86%
ENOV annual capital expenditures is up +47.86% year-on-year

Free Cash Flow

Free Cash Flow

-$67.21M
ENOV annual free cash flow is -$67.21 million

Free Cash Flow 1-year Change

-626.52%
ENOV annual free cash flow is down -626.52% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

56.02%
ENOV annual gross profit margin is 56.02%

Operating Margin

-4.91%
ENOV annual operating profit margin is -4.91%

Net Margin

-39.17%
ENOV annual net profit margin is -39.17%

ROA & ROE

ROA

-17.89%
ENOV annual return on assets is -17.89%

ROE

-27.59%
ENOV annual return on equity is -27.59%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ENOV price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ENOV price to earnings ratio is unknown

PB Ratio

PB Ratio

0.83
ENOV price to book ratio is 0.83

PB Ratio Sector Rank

39.54%
ENOV price to book ratio is higher than 39.54% of companies in Healthcare sector

PS Ratio

PS Ratio

1.00
ENOV price to sales ratio is 1.00

PS Ratio Sector Rank

26.26%
ENOV price to sales ratio is higher than 26.26% of companies in Healthcare sector

Enterprise value

Enterprise Value

$3.47B
ENOV enterprise value is $3.47 billion

Enterprise Value Sector Rank

85.88%
ENOV enterprise value is higher than 85.88% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-7.22
ENOV EV/EBITDA is -7.22

EV/EBITDA Sector Rank

15.06%
ENOV EV/EBITDA is higher than 15.06% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

2.17
ENOV annual current ratio is 2.17

Quick Ratio

1.13
ENOV annual quick ratio is 1.13

Leverage

Debt To Equity

0.52
ENOV annual debt to equity ratio is 0.52

Interest Coverage Ratio

-13.41
ENOV annual interest coverage ratio is -13.41

Risk & Stability

Piotroski F-Score

3
ENOV piotroski f-score is 3

Altman Z-Score

0.57
ENOV altman z-score is 0.57

Analyst ratings

Recent major analysts updates

Feb 27, 25 Needham
Buy
Nov 7, 24 Needham
Buy
Oct 3, 24 JMP Securities
Market Outperform
Oct 1, 24 Evercore ISI Group
Outperform
Aug 8, 24 Needham
Buy
Aug 8, 24 JP Morgan
Neutral
Jul 2, 24 Evercore ISI Group
Outperform
Jun 13, 24 JP Morgan
Neutral
May 3, 24 Needham
Buy
Apr 10, 24 Needham
Buy

Institutional Ownership

Similar stocks

LIVN logo
LivaNova (LIVN)
Belite Bio (BLTE)
VCEL logo
Vericel (VCEL)
MIRM logo
Mirum Pharmaceuticals (MIRM)
SEM logo
Select Medical Holdings (SEM)
APGE logo
Apogee Therapeutics (APGE)
RXRX logo
Recursion Pharmaceuticals (RXRX)
NAMS logo
NewAmsterdam Pharma Company NV (NAMS)
LGND logo
Ligand Pharmaceuticals Incorporated (LGND)
  • What is the ticker symbol for Enovis?
  • Does Enovis pay dividends?
  • What sector is Enovis in?
  • What industry is Enovis in?
  • What country is Enovis based in?
  • When did Enovis go public?
  • Is Enovis in the S&P 500?
  • Is Enovis in the NASDAQ 100?
  • Is Enovis in the Dow Jones?
  • When was Enovis's last earnings report?
  • When does Enovis report earnings?
  • Should I buy Enovis stock now?

What is the ticker symbol for Enovis?

The ticker symbol for Enovis is NYSE:ENOV

Does Enovis pay dividends?

No, Enovis does not pay dividends

What sector is Enovis in?

Enovis is in the Healthcare sector

What industry is Enovis in?

Enovis is in the Medical Devices industry

What country is Enovis based in?

Enovis is headquartered in United States

When did Enovis go public?

Enovis's initial public offering (IPO) was on May 8, 2008

Is Enovis in the S&P 500?

No, Enovis is not included in the S&P 500 index

Is Enovis in the NASDAQ 100?

No, Enovis is not included in the NASDAQ 100 index

Is Enovis in the Dow Jones?

No, Enovis is not included in the Dow Jones index

When was Enovis's last earnings report?

Enovis's most recent earnings report was on Feb 26, 2025

When does Enovis report earnings?

The next expected earnings date for Enovis is May 2, 2025

Should I buy Enovis stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page